Table 1.
Study population providing plasma samples
| Receptor | n | Number of plasma samples/child Mean (range) |
Median age (months)a | Number of previous infections Mean (SD)a |
|---|---|---|---|---|
| CD36 | 129 | 1.6 (1–3) | 21.0 | 3.3 (2.6) |
| Cell. Fibronectin | 105 | 1.9 (1–2) | 18.3 | 2.9 (2.0) |
| ICAM-1 | 137 | 1.4 (1–3) | 14.7 | 2.8 (2.1) |
| Integrin αvβ3 | 110 | 1.7 (1–4) | 22.0 | 2.7 (2.1) |
| Integrin α3β1 | 120 | 1.8 (1–5) | 24.2 | 2.6 (1.9) |
| Integrin α5β1 | 129 | 2.1 (1–4) | 28.6 | 2.8 (2.2) |
| JAM-B | 138 | 2.0 (1–3) | 17.8 | 2.7 (1.9) |
| Laminin | 112 | 1.9 (1–4) | 18.4 | 2.7 (2.1) |
| PECAM-1 | 166 | 1.9 (1–4) | 18.3 | 2.7 (2.0) |
| P-selectin | 82 | 1.3 (1–3) | 23.8 | 2.4 (1.8) |
| IE surface (flow) | 106 | 2.0 (1–2) | 18.4 | 2.8 (2.0) |
aFor children providing multiple samples, age and number of previous infections at each time point were included